Incidence trends of prostate cancer in East Anglia, before and during the era of PSA diagnostic testing

Por Pashayan, N, Powles, J, Brown, C, Duffy, S W
Publicado em 2006

Excess cases of prostate cancer and estimated overdiagnosis associated with PSA testing in East Anglia

Por Pashayan, N, Powles, J, Brown, C, Duffy, S W
Publicado em 2006

Excess cases of prostate cancer and estimated overdiagnosis associated with PSA testing in East Anglia

Por Pashayan, N, Powles, J, Brown, C, Duffy, S W
Publicado em 2006

Survival trends for small intestinal cancer in England and Wales, 1971–1990: national population-based study

Por Pashayan, N, Lepage, C, Rachet, B, Woods, L M, Coleman, M P
Publicado em 2006

Public health genomics and personalized prevention: lessons from the COGS project

Por Pashayan, N, Hall, A, Chowdhury, S, Dent, T, Pharoah, P D P, Burton, H
Publicado no J Intern Med (2013)

Implementing risk-stratified screening for common cancers: a review of potential ethical, legal and social issues

Por Hall, A.E., Chowdhury, S., Hallowell, N., Pashayan, N., Dent, T., Pharoah, P., Burton, H.
Publicado em 2014

Mean sojourn time, overdiagnosis, and reduction in advanced stage prostate cancer due to screening with PSA: implications of sojourn time on screening

Por Pashayan, N, Duffy, S W, Pharoah, P, Greenberg, D, Donovan, J, Martin, R M, Hamdy, F, Neal, D E
Publicado em 2009

Polygenic susceptibility to prostate and breast cancer: implications for personalised screening

Por Pashayan, N, Duffy, S W, Chowdhury, S, Dent, T, Burton, H, Neal, D E, Easton, D F, Eeles, R, Pharoah, P
Publicado em 2011